Recent Finacing
Recent Raise
StrideBio develops structure-guided engineered AAV capsids and in vivo gene delivery vectors to reduce antibody binding, improve neuronal and cardiovascular tropism, de-target liver and advance CNS, cardiovascular gene therapies.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
